Calcimedica to host acute pancreatitis clinical experts event on september 21, 2023

La jolla, calif. , aug. 31, 2023 /prnewswire/ -- calcimedica inc. ("calcimedica") (nasdaq: calc), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (crac) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that it will host a virtual clinical experts event on thursday, september 21, 2023, from 10:30 a.m.
CALC Ratings Summary
CALC Quant Ranking